Volume 13, Issue 10, Pages (May 2003)

Slides:



Advertisements
Similar presentations
MLANA/MART1 and SILV/PMEL17/GP100 Are Transcriptionally Regulated by MITF in Melanocytes and Melanoma  Jinyan Du, Arlo J. Miller, Hans R. Widlund, Martin.
Advertisements

Role of Bmi-1 and Ring1A in H2A Ubiquitylation and Hox Gene Silencing
Volume 11, Issue 4, Pages (April 2007)
CBP and p300 are recruited to MYC target genes.
Volume 55, Issue 1, Pages (July 2014)
Volume 19, Issue 4, Pages (August 2005)
Marios Agelopoulos, Daniel J. McKay, Richard S. Mann  Cell Reports 
Stimulation of V(D)J recombination by histone acetylation
Volume 15, Issue 5, Pages (November 2001)
Induction of Somatic Hypermutation Is Associated with Modifications in Immunoglobulin Variable Region Chromatin  Caroline J. Woo, Alberto Martin, Matthew.
Volume 13, Issue 5, Pages (March 2004)
IFN-γ Upregulates Expression of the Mouse Complement C1rA Gene in Keratinocytes via IFN-Regulatory Factor-1  Sung June Byun, Ik-Soo Jeon, Hyangkyu Lee,
The interferon regulatory factor ICSBP/IRF-8 in combination with PU
Volume 36, Issue 2, Pages (October 2009)
Volume 16, Issue 6, Pages (December 2004)
Rose-Anne Romano, Barbara Birkaya, Satrajit Sinha 
Inhibition of DNA Methylation in the COL1A2 Promoter by Anacardic Acid Prevents UV- Induced Decrease of Type I Procollagen Expression  Min-Kyoung Kim,
Demethylation of a nonpromoter cytosine-phosphate-guanine island in the aromatase gene may cause the aberrant up-regulation in endometriotic tissues 
John T. Arigo, Kristina L. Carroll, Jessica M. Ames, Jeffry L. Corden 
Volume 22, Issue 4, Pages (May 2006)
Histone Modifications Associated with Somatic Hypermutation
Peroxisome Proliferator-Activated Receptor-α Is a Functional Target of p63 in Adult Human Keratinocytes  Silvia Pozzi, Michael Boergesen, Satrajit Sinha,
Daniel Wolf, Stephen P. Goff  Cell 
Volume 13, Issue 1, Pages (July 2013)
Volume 14, Issue 19, Pages (October 2004)
Induction of Somatic Hypermutation Is Associated with Modifications in Immunoglobulin Variable Region Chromatin  Caroline J. Woo, Alberto Martin, Matthew.
Mapping Global Histone Acetylation Patterns to Gene Expression
Functional Modulation of Gene Expression by Ultraconserved Long Non-coding RNA TUC338 during Growth of Human Hepatocellular Carcinoma  Hui-Ju Wen, Michael.
Volume 18, Issue 2, Pages (April 2005)
An Acetylation Switch in p53 Mediates Holo-TFIID Recruitment
John T. Arigo, Daniel E. Eyler, Kristina L. Carroll, Jeffry L. Corden 
Cell-Type-Specific Control of Enhancer Activity by H3K9 Trimethylation
Phosphorylation of Serine 2 within the RNA Polymerase II C-Terminal Domain Couples Transcription and 3′ End Processing  Seong Hoon Ahn, Minkyu Kim, Stephen.
Yugong Ho, Felice Elefant, Stephen A. Liebhaber, Nancy E. Cooke 
Minchul Kim, Taekhoon Kim, Randy L. Johnson, Dae-Sik Lim  Cell Reports 
Volume 7, Issue 9, Pages (September 2014)
Xiaolong Wei, Hai Xu, Donald Kufe  Cancer Cell 
Epigenetic Silencing of the p16INK4a Tumor Suppressor Is Associated with Loss of CTCF Binding and a Chromatin Boundary  Michael Witcher, Beverly M. Emerson 
Neal Sugawara, Xuan Wang, James E. Haber  Molecular Cell 
Volume 16, Issue 4, Pages (November 2004)
CRISPR/dCas9-mediated Transcriptional Inhibition Ameliorates the Epigenetic Dysregulation at D4Z4 and Represses DUX4-fl in FSH Muscular Dystrophy  Charis.
Defining the CREB Regulon
Volume 13, Issue 6, Pages (June 2013)
Volume 38, Issue 3, Pages (May 2010)
Andrew W Snowden, Philip D Gregory, Casey C Case, Carl O Pabo 
Spatial and Temporal Recruitment of Androgen Receptor and Its Coactivators Involves Chromosomal Looping and Polymerase Tracking  Qianben Wang, Jason S.
Volume 9, Issue 6, Pages (June 2002)
Rif1 and Rif2 Inhibit Localization of Tel1 to DNA Ends
Histone Modifications Associated with Somatic Hypermutation
Volume 132, Issue 6, Pages (March 2008)
ADAR Regulates RNA Editing, Transcript Stability, and Gene Expression
Xudong Wu, Jens Vilstrup Johansen, Kristian Helin  Molecular Cell 
Dimethylation of H3K4 by Set1 Recruits the Set3 Histone Deacetylase Complex to 5′ Transcribed Regions  TaeSoo Kim, Stephen Buratowski  Cell  Volume 137,
Volume 36, Issue 2, Pages (October 2009)
Distinct Pathways for snoRNA and mRNA Termination
Tsix Silences Xist through Modification of Chromatin Structure
Volume 14, Issue 4, Pages (May 2004)
Feng Xu, Qiongyi Zhang, Kangling Zhang, Wei Xie, Michael Grunstein 
Volume 8, Issue 2, Pages (August 2001)
Volume 29, Issue 1, Pages (January 2008)
Volume 41, Issue 2, Pages (January 2011)
The Human DiGeorge Syndrome Critical Region Gene 8 and Its D
Volume 14, Issue 24, Pages (December 2004)
MicroRNA Binding Sites in Arabidopsis Class III HD-ZIP mRNAs Are Required for Methylation of the Template Chromosome  Ning Bao, Khar-Wai Lye, M.Kathryn.
PU.1 Expression Delineates Heterogeneity in Primary Th2 Cells
Chk1 and 14‐3‐3 proteins inhibit atypical E2Fs to prevent a permanent cell cycle arrest Experimental procedures of the SILAC assay to identify binding.
Volume 2, Issue 4, Pages (October 2012)
Volume 15, Issue 16, Pages (August 2005)
Pirh2 represses p73-dependent transactivation.
Role of Bmi-1 and Ring1A in H2A Ubiquitylation and Hox Gene Silencing
Presentation transcript:

Volume 13, Issue 10, Pages 882-886 (May 2003) Analysis of Myc Bound Loci Identified by CpG Island Arrays Shows that Max Is Essential for Myc-Dependent Repression  Daniel Y.L. Mao, John D. Watson, Pearlly S. Yan, Dalia Barsyte-Lovejoy, Fereshteh Khosravi, W.Wei-Lynn Wong, Peggy J. Farnham, Tim H.-M. Huang, Linda Z. Penn  Current Biology  Volume 13, Issue 10, Pages 882-886 (May 2003) DOI: 10.1016/S0960-9822(03)00297-5

Figure 1 Myc Binds to Activated and Repressed Genes in HL60 Cells ChIP assays with anti-c-Myc antibody (N-262, Santa Cruz) (lane 1) or no antibody (lane 2) from logarithmically growing human HL60 cells were performed as described. Additional control reactions include a no template mock IP (lane 3) and a 1×, 1/2×, and 1/4× titration of input chromatin (lanes 4–6). DNA was PCR amplified by using primers designed against the regulatory regions indicated. This includes an activated gene (cad) and an E box on chromosome 22 (chrm22 E box) that serve as a positive and negative control, respectively, for binding by Myc, as well as Myc-activated and -repressed genes previously identified as downstream of Myc by cDNA expression array analysis. Sequences for ChIP-PCR primers are available upon request. Current Biology 2003 13, 882-886DOI: (10.1016/S0960-9822(03)00297-5)

Figure 2 Conventional ChIP Analysis Confirms that Myc Binds to the Novel Loci Identified by the Combined ChIP-CpG Island Microarray Screen ChIP assays with anti-c-Myc antibody (lane 1) or no antibody (lane 2) from logarithmically growing human HL60 cells. Additional control reactions include a 1×, 1/2×, and 1/4× titration of input chromatin (lanes 3–5) and a no template mock IP (lane 6). DNA was PCR amplified by using primers designed against a positive control (cad), negative control (chrm22 E box), and the sequences of ten randomly selected positive clones. Two negative clones that had hybridization ratios <3-fold were randomly selected and are also shown. The shaded bars to the right represent the fold binding observed on each of two independent microarray hybridizations (I and II) for each clone. Current Biology 2003 13, 882-886DOI: (10.1016/S0960-9822(03)00297-5)

Figure 3 Max Binds to Myc Bound Genes before and after Myc Protein Recruitment (A) ChIP assays with anti-c-Myc (lane 1), anti-Max (C-124, Santa Cruz) (lane 2), or no antibody (lane 3) from logarithmically growing HL60 cells. Additional control reactions include a 1×, 1/2×, and 1/4× titration of input chromatin (lanes 4–6) and a no template mock IP (lane 7). gadd45a (shown at top) is a known Myc-repressed gene. Below are five randomly selected positive clones (dleu1/2, d1s155e, dkfzp586c1924, ube2c, and mthfd1), which were amplified by PCR by using primers designed against each locus. The shaded bars (to their right) represent the fold binding observed on each of two independent microarray hybridizations (I and II) for each clone. (B) mRNA expression of genes whose regulatory regions are bound by Myc, as assessed by reverse transcriptase (RT)-PCR in logarithmically growing (lanes 1 and 3) and DMSO-treated (lanes 2 and 4) HL60 cells. A set of cDNA amplified under no RT conditions (lanes 3 and 4) are included as controls to evaluate genomic DNA contamination. Sequences for RT-PCR primers are available upon request. An asterisk indicates that the mRNA expression of dleu1 and dleu2, referred to as dleu1/2, was similarly regulated; thus, a representative panel is shown. Genes that are repressed (R) or activated (A) by c-myc expression are indicated. (C) ChIP assays with anti-c-Myc (lanes 1, 6, and 11), anti-Max (lanes 2, 7, and 12), or no antibody (lanes 3, 8, and 13) from LOG- and DMSO-treated HL60 cells. Additional control reactions include a no template mock IP (lanes 4, 9, and 14) and 1× input chromatin to control for the PCR reaction (lanes 5, 10, and 15). DNA was PCR amplified by using primers designed against Myc-activated (apex) and Myc-repressed (cdkn2b, d1s155e, dkfp586c1924, fads2, and n-pac) genes, as well as a negative control (chrm22 E box). Current Biology 2003 13, 882-886DOI: (10.1016/S0960-9822(03)00297-5)

Figure 4 Max Can Bind to Genes Independently of Myc, and the Myc:Max Interaction Is Essential for Myc to Repress Gene Expression (A) ChIP assays with anti-c-Myc (lanes 1 and 5), anti-Max (lanes 9 and 13), or no antibody (lanes 2, 6, 10, and 14) in Rat1c-myc−/− cells infected with an ecotropic retrovirus carrying c-myc or empty vector. Additional control reactions include 1× input chromatin (lanes 3, 7, 11, and 15) and a no template mock IP (lane 4, 8, 12, and 16). DNA was PCR amplified by using primers against Myc-activated (cad) and Myc-repressed (gadd45, c-myc, and tde1) genes, as well as a negative control (gck). (B) RT-PCR expression analysis of Myc-repressed genes in subconfluent, asynchronous Rat-1c-myc−/− cells that ectopically express Myc, Max, MycEG, and/or MaxEG. 36B4 was assayed as a control for equivalent loading. Current Biology 2003 13, 882-886DOI: (10.1016/S0960-9822(03)00297-5)